MTOR and diabetic kidney disease: Antidiabetics, like Metformin, evidenced lower podocyte destruction, mesangial cells apoptosis and tubulointerstitial cell senescence via AMPK and mammalian target of rapamycin (mTOR) regulation in diabetic nephropathy.